Bailard, Inc. Chimerix Inc Transaction History

Bailard, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	BUY	$1.19 - $2.09 $39,984 - $70,224	33,600 New	33,600 $42,000
Q2 2022 Jul 27, 2022	BUY	$1.34 - $5.34 $91,254 - $363,654	68,100 New	68,100 $142,000
Q4 2021 Feb 10, 2022	SELL	$5.23 - $7.18 $177,297 - $243,402	-33,900 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.94 - $8.75 $74,250 - $109,375	12,500 Added 58.41%	33,900 $210,000
Q2 2021 Aug 13, 2021	BUY	$7.54 - $9.79 $161,356 - $209,505	21,400 New	21,400 $171,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.